CTOR   $1.1400000000000001  -3.39% Market Closed After Close 1.1 -3.51%

Citius Oncology Inc
Total Cash
totalCashPerShare
EBITDA
Total Debt 0.00
quickRatio
currentRatio 0.319
Total Revenue
debtToEquity
Revenue/Share
ROA -0.24232
ROE -0.85276
grossProfits
freeCashflow 7.11M
operatingCashflow 0.00
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue
forwardPE
floatShares 4.97M
sharesOutstanding 71.30M
sharesShort 51.54K
sharesShortPriorMonth 1.17K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.96%
heldPercentInstitutions 0.05%
Short Ratio help_outline 0.05%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.252
Price To Book help_outline 4.52
earningsQuarterlyGrowth
netIncomeToCommon -19.52M
trailingEps -0.18%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 17
lastUpdated Nov. 2, 2024, 7:56 a.m.